FindTrial
Sign In

The effect of Sirdalud (Tizanidin) on post percutaneous nephrolithotomy pain

The effect of preemptive Single dose of Sirdalud(Tizanidin) tablet in post operative percutaneous nephrolitotomy pain control

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201310281772N12
Enrollment
60
Registered
2013-11-22
Start date
2012-10-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

percutaneous nephrolithotomy. Calculus of kidney

Interventions

Intervention 1: Without taking Sirdalud tablet 2mg, One hour before Anesthesia in the control group. Intervention 2: Taking Sirdalud tablet 2mg, One hour before Anesthesia in the intervention group.
Treatment - Drugs
Without taking Sirdalud tablet 2mg, One hour before Anesthesia in the control group
Taking Sirdalud tablet 2mg, One hour before Anesthesia in the intervention group

Sponsors

Research team of anesthesiology, Tabriz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were: age between 20-60 years; candidate for percutaneous nephrolithotomy exclusion criteria were: drug addiction, history of pain killer drugs, drug sensitivity and patient‘s lack of consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 0,2, 6, 12, 24 o'clock postoperative. Method of measurement: Visual Anlogue Scale.—

Secondary

MeasureTime frame
Analgesic drugs. Timepoint: 0,2, 6, 12, 24 o'clock postoperative. Method of measurement: Milligram/ Dose.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDawood Aghamohammadi

Anesthesiology Dept

aghamohammadid@tbzmed.ac.ir+98 41 1334 1994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026